Gene medicines - From bench to bedside. Guidance for handling of gene medicines in the hospital pharmacy developed by the European Association of Hospital Pharmacists.
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Presentation
- By: STONER, Nicola (Oxford Radcliffe Hospital NHS Trust, Oxford, United Kingdom)
- Co-author(s): Vulto, Arnold (Hospital Pharmacy Erasmus University Medical Centre, Rotterdam, Netherlands)
Balasova, Hana (Department of Pharmacy, University Hospital, Brno, Czech Republic)
Cercos, Ana-Cristina (La Fe University Hospitals, Valencia, Spain)
Hoppe Tichy, Torsten (University Hospital of Heidelberg, Heidelberg, Germany)
Vinent Genestar, Juan (St Joan de Déu Hospital, Barcelona, Spain)
Kontra, Kirsi (Department of Pharmacy, University Hospital, Kuopio, Finland)
Nydert, Per (Hospital Pharmacies, Karolinska University Hospital Huddinge, Stockholm, Sweden)
Vermes, Andras (Hospital Pharmacy Erasmus University Medical Centre, Rotterdam, Netherlands)
Wolfsberger, Andrea (Allgemeines Krankenhaus-Universitätskliniken, Vienna, Austria)
Background: Several gene medicine products are in phase III clinical trials, and the first gene medicines is licensed as a pharmaceutical in China. Hospital pharmacists are responsible for procurement, storage and further handling (reconstitution) in the hospital, as is the case with other drugs. Guidance is required for pharmacy staff on handling.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.